← Back to Discover

SymBiosis Capital Partners, LLC

Period ended Mar 31, 2026 · Latest filing May 12, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Mar 31, 2026: $52,769,920

More quarters will appear as history becomes available.

Top holdings

Top 10 at Mar 31, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. Evommune, Inc. · COM SHS · 30054Y107 · shares: $29,445,086
  2. Inventiva S.A. · ADS · 46124U107 · shares: $13,064,700
  3. Wave Life Sciences Ltd. · SHS · Y95308105 · shares: $5,437,500
  4. Rani Therapeutics Holdings, Inc. · COM CL A · 753018100 · shares: $2,694,941
  5. Clene Nanomedicine Inc. · COM NEW · 185634201 · shares: $2,125,293
  6. Surrozen, Inc. · *W EXP 08/01/203 · 86889P117 · shares: $2,400

Reported holdings

6 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
Evommune, Inc.COM SHS30054Y107 — 1,280,778 shares $29,445,086
Inventiva S.A.ADS46124U107 — 2,354,000 shares $13,064,700
Wave Life Sciences Ltd.SHSY95308105 — 750,000 shares $5,437,500
Rani Therapeutics Holdings, Inc.COM CL A753018100 — 3,667,585 shares $2,694,941
Clene Nanomedicine Inc.COM NEW185634201 — 431,094 shares $2,125,293
Surrozen, Inc.*W EXP 08/01/20386889P117 — 150,000 shares $2,400